Login / Signup
Methylation of FAM110C is a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancer.
Fengna Liu
Aiai Gao
Meiying Zhang
Yazhuo Li
Fan Zhang
James G Herman
Mingzhou Guo
Published in:
Journal of translational internal medicine (2024)
methylation is a potential diagnostic and prognostic marker in PDAC, and its epigenetic silencing sensitizes PDAC cells to ATR/CHK1 inhibitors.
Keyphrases
</>
dna damage response
induced apoptosis
dna methylation
genome wide
endoplasmic reticulum stress
cell cycle arrest
gene expression
signaling pathway
oxidative stress
dna repair
risk assessment